Dr. Jasper Boeddinghaus and Dr. C. Michael Gibson discuss: PRESC1SE-MI: Safety and efficacy of the ESC 0/1-hour algorithm and Performance of 0/1-hour versus standard care pathways in myocardial infarction: a systematic review and IPDMA August 29, 2026 Disclosures: TBD
Dr. Marco Valgimigli and Dr. C. Michael Gibson discuss: EnVast thrombectomy device as adjunctive reperfusion modality in ST-segment elevation myocardial infarction August 29, 2026 Disclosures:TBD
Dr. Byeong-Keuk Kim and Dr. C. Michael Gibson discuss: A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI August 29, 2026 Disclosures: TBD
Dr. Elmir Omerovic and Dr. C. Michael Gibson discuss: SWITCH SWEDEHEART – Switching from ticagrelor to prasugrel in patients with ACS August 29, 2026 Disclosures: TBD
Dr. Philippe Gabriel Steg and Dr. C. Michael Gibson discuss: LIBREXIA ACS: Milvexian after recent ACS August 29, 2026 Disclosures: TBD
Dr. Tor Biering-Sorensen and Dr. C. Michael Gibson discuss: DAN-RSV: RSVpreF vaccine for preventing cardiorespiratory hospitalisations August 29, 2026 Disclosures: TBD
Dr. Ashkan Shoamanesh and Dr. C. Michael Gibson discuss: ENRICH-AF: Edoxaban in intracranial hemorrhage survivors with atrial fibrillation August 29, 2026 Disclosures: TBD
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss: TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug (IL-6 ligand mAb) targeting inflammation in CKD with high cardiovascular risk August 29, 2026 Disclosures: TBD
Dr. Ashish Sarraju and Dr. C. Michael Gibson discuss: Extremely Long Duration Lp(a) Reduction Following a Single Dose of Kylo-11: Final Data from a First-in-Human Study August 28, 2026 Disclosures: TBD
